Metabolic biomarkers in cancer

Kacper Szczepski, Inas Al-Younis, Manel Dhahri, Joanna Izabela Lachowicz, Zeyad Al-Talla, Hanan Almahasheer, Noura Salman Alasmael, Mahbuba Rahman, Abdul-Hamid M. Emwas, Lukasz Jaremko, Mariusz Jaremko

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Over the course of years healthcare systems have utilized various “-omics” approaches to prognose, diagnose, and evaluate the treatment efficacy of cancer diseases. Metabolomics is one of the latest prominent additions to the -omics approaches, characterized by its versatile methodology. Owing to constant improvements in the field, metabolomics aims to provide a faster and a more accurate diagnosis, as well as personalized and optimal strategies of treatment. In recent years, a growing number of studies have utilized metabolomics approach to find new disease-related biomarkers of cancer diseases. Here we present the summary of recent advances in biomarker discovery for various types of cancers such as leukemia, ovarian, lung, breast, and liver cancers as well as cancer-related cachexia.
Original languageEnglish (US)
Title of host publicationMetabolomics
PublisherElsevier
Pages173-198
Number of pages26
ISBN (Print)9780323999243
DOIs
StatePublished - Jan 27 2023

Fingerprint

Dive into the research topics of 'Metabolic biomarkers in cancer'. Together they form a unique fingerprint.

Cite this